The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Chronic Granulomatous Disease
Abstract
Chronic granulomatous disease (CGD) was first described in the 1950s and has become a paradigm for genetic neutrophil diseases. It is characterized by recurrent infections with a narrow spectrum of bacteria and fungi as well as a common set of inflammatory complications most notably including inflammatory bowel disease. Over the last half century major advances in management have profoundly altered the major clinical issues and the life expectancy of CGD. With X-linked and autosomal recessive forms, it has been an important disease for the development of bone marrow transplantation and gene therapy. Some of the recent developments in infectious syndromes, inflammatory complications, and curative approaches are discussed in this review.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most mutations causing the disease (around 90%) are found in the membrane component NOX2 (also known historically as gp91phox) and the interacting protein p47phox.”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [438]
In the citing paper
“Genetic defects in the main constituents of NOX2 can trigger an inability of the immune system cells to kill invading bacteria and fungi.”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [438]
Citations
Cites
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Self-citationKilling activity of neutrophils is mediated through activation of proteases by K+ flux
Reeves, E. P., Lu, H., Jacobs, H. L., Messina, C. G. M., Bolsover, S., Gabella, G., Potma, E. O., Warley, A., Roes, J., & Segal, A. W. (2002) · Nature · doi:10.1038/416291a · Cited by 1,153
Genetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L., & Holland, S. M. (2000) · Medicine · doi:10.1097/00005792-200005000-00004 · Cited by 887
Self-citationA Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 832
NADPH oxidase–derived free radicals are key oxidants in alcohol-induced liver disease
Kono, H., Rusyn, I., Yin, M., Gäbele, E., Yamashina, S., Dikalova, A., Kadiiska, M. B., Connor, H. D., Mason, R. P., Segal, B. H., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9020 · Cited by 493
Self-citationp47phox is required for atherosclerotic lesion progression in ApoE–/– mice
Barry-Lane, P. A., Patterson, C., van der Merwe, M., Hu, Z., Holland, S. M., Yeh, E. T. H., & Runge, M. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111927 · Cited by 489
Self-citationGastrointestinal Involvement in Chronic Granulomatous Disease
Marciano, B. E., Rosenzweig, S. D., Kleiner, D. E., Anderson, V., Darnell, D. N., Anaya‐O’Brien, S., Hilligoss, D. M., Malech, H. L., Gallin, J. I., & Holland, S. M. (2004) · PEDIATRICS · doi:10.1542/peds.114.2.462 · Cited by 417
Self-citationLocalizing NADPH Oxidase–Derived ROS
Ushio‐Fukai, M. (2006) · Science s STKE · doi:10.1126/stke.3492006re8 · Cited by 397
Itraconazole to Prevent Fungal Infections in Chronic Granulomatous Disease
Gallin, J. I., Alling, D. W., Malech, H. L., WESLEY, R. A., Koziol, D. E., Marciano, B. E., Eisenstein, E. M., Turner, M. L. C., DeCarlo, E. S., Starling, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021931 · Cited by 394
Self-citationMorgenstern, D. E., Gifford, M. A. C., Li, L. L., Doerschuk, C. M., & Dinauer, M. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.2.207 · Cited by 370
Research works printed but not linked: 1
- Janeway CA, Craig J, Davidson M, Downey W, Gitlin D, Sullivan JC (1954) Hypergammaglobulinemia associated with severe, recurrent and chronic non-specific infection. Am J Dis Child 88:388–392
Cited by
Sorted by citations
Items 101–200 of 326
ICON: The Early Diagnosis of Congenital Immunodeficiencies
Routes, J. M., Abinun, M., Al–Herz, W., Bustamante, J. C., Condino‐Neto, A., de la Morena, M. T., Etzioni, A., Gambineri, E., Haddad, É., Kobrynski, L. J., et al. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0003-x · Cited by 46
Chen, W., Liu, Y., Zhang, L., Gu, X., Liu, G., Shahid, M. S., Gao, J., Ali, T., & Han, B. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00194 · Cited by 44
Microbes and the fate of neutrophils
Kobayashi, S. D., DeLeo, F. R., & Quinn, M. T. (2022) · Immunological Reviews · doi:10.1111/imr.13163 · Cited by 45
An Update on the Use of Immunomodulators in Primary Immunodeficiencies
Vignesh, P., Rawat, A. K., & Singh, S. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8591-2 · Cited by 45
Recent advances in chronic granulomatous disease
Goldblatt, D. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.07.013 · Cited by 43
Yan, J., Hedl, M., & Abraham, C. (2017) · Journal of Clinical Investigation · doi:10.1172/jci86282 · Cited by 42
Dotis, J., & Roilides, E. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.02001.x · Cited by 41
Neutrophils augment LPS-mediated pro-inflammatory signaling in human lung epithelial cells
Boots, A. W., Gerloff, K., Bartholomé, R., van Berlo, D., Ledermann, K., Haenen, G. R. M. M., Bast, A., van Schooten, F., Albrecht, C., & Schins, R. P. F. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.04.012 · Cited by 40
Bone Marrow Transplantation for Primary Immunodeficiency Diseases
Szabolcs, P., Cavazzana, M., Fischer, A., & Veys, P. A. (2010) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2009.12.004 · Cited by 41
Sürün, D., Schwäble, J., Tomasovic, A., Ehling, R., Stein, S., Kurrle, N., von Melchner, H., & Schnütgen, F. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2017.11.001 · Cited by 39
Ranjan, K., Hedl, M., Sinha, S., Zhang, X., & Abraham, C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145472 · Cited by 39
Antas, P. R. Z., Brito, M. M. S., Peixoto, É., Ponte, C., & Borba, C. D. M. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.08.004 · Cited by 39
Nox2 protects against prolonged inflammation, lung injury, and mortality following systemic insults
Whitmore, L. C., Hilkin, B. M., Goss, K. L., Wahle, E. M., Colaizy, T. T., Boggiatto, P. M., Varga, S. M., Miller, F. J., & Moreland, J. G. (2013) · Journal of Innate Immunity · doi:10.1159/000347212 · Cited by 38
Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment
Fernandez-Boyanapalli, R. F., Falcone, E. L., Zerbe, C. S., Marciano, B. E., Frasch, S. C., Henson, P. M., Holland, S. M., & Bratton, D. L. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.034 · Cited by 38
Self-citationBrendel, C., Rothe, M., Santilli, G., Charrier, S., Stein, S., Kunkel, H., Abriss, D., Müller-Kuller, U., Gaspar, H. B., Modlich, U., et al. (2018) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2017.245 · Cited by 36
Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience
Hawary, R. E., Meshaal, S. S., Deswarte, C., Galal, N. M., Abdelkawy, M., Alkady, R., Elaziz, D. S. A., Freiberger, T., Ravčuková, B., Litzman, J., et al. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0297-y · Cited by 36
War-Fe-re: iron at the core of fungal virulence and host immunity
Nevitt, T. (2011) · BioMetals · doi:10.1007/s10534-011-9431-8 · Cited by 35
Hayrapetyan, A., Dencher, P. C. D., van Leeuwen, K., de Boer, M., & Roos, D. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.001 · Cited by 35
Diagnostic approach to primary immunodeficiency disorders
Madkaikar, M. R., Mishra, A., & Ghosh, K. (2013) · Indian Pediatrics · doi:10.1007/s13312-013-0171-4 · Cited by 33
Application of Flow Cytometry in Primary Immunodeficiencies: Experience From India
Madkaikar, M. R., Shabrish, S., Kulkarni, M., Aluri, J., Dalvi, A. D., Kelkar, M. G., & Gupta, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01248 · Cited by 33
Analysis of intracellular enzyme activity by surface enhanced Raman scattering
Stevenson, R., McAughtrie, S., Senior, L., Stokes, R. J., McGachy, H. A., Tetley, L., Nativo, P., Brewer, J. M., Alexander, J. K., Faulds, K., et al. (2013) · The Analyst · doi:10.1039/c3an00729d · Cited by 32
Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions
Hultqvist, M. H., Olofsson, P., Wallner, F. K., & Holmdahl, R. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5788 · Cited by 31
Huang, C., Hedl, M., Ranjan, K., & Abraham, C. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.105 · Cited by 30
Evasion of Immunological Memory by S. aureus Infection: Implications for Vaccine Design
Teymournejad, O., & Montgomery, C. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633672 · Cited by 30
Hedl, M., & Abraham, C. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00297.2012 · Cited by 31
Paediatric Behçet’s Disease: A Comprehensive Review with an Emphasis on Monogenic Mimics
Cınar, O. K., Romano, M., Güzel, F., Brogan, P. A., & Demirkaya, E. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051278 · Cited by 28
Regulation of immune responses by proton channels
Capasso, M. (2014) · Immunology · doi:10.1111/imm.12326 · Cited by 28
Clinical and Molecular Features of 38 Children with Chronic Granulomatous Disease in Mainland China
Xu, H., Tian, W., Li, S., Zhang, L., Liu, W., Zhao, Y., Zhang, Z., Tang, X., Wang, M., Wu, D., et al. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0061-0 · Cited by 28
Klatt, D., Cheng, E., Philipp, F., Selich, A., Dahlke, J., Schmidt, R. E., Schott, J. W., Büning, H., Hoffmann, D., Thrasher, A. J., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.008 · Cited by 28
Tímár, C. I., Lőrincz, Á. M., & Ligeti, E. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1285-1 · Cited by 27
NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome
Whitmore, L. C., Goss, K. L., Newell, E. A., Hilkin, B. M., Hook, J. S., & Moreland, J. G. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00054.2014 · Cited by 27
Crestani, E., Volpi, S., Candotti, F., Giliani, S. C., Notarangelo, L. D., Chu, J., Becerra, J. C. A., Buchbinder, D., Chou, J. S., Geha, R. S., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.08.010 · Cited by 27
Zhang, B. Z., Yan, H., Yu, B., Lau, C. C. Y., Cai, J., Zheng, S. Y., Yam, W. C., Kao, R. Y. T., Sze, K. H., Zheng, B. J., et al. (2014) · Infection and Immunity · doi:10.1128/iai.02498-14 · Cited by 26
Immune Response Resetting in Ongoing Sepsis
Nowill, A. E., Fornazin, M. C., Spago, M. C., Neto, V. D., Pinheiro, V. R. P., Alexandre, S. S. S., Moraes, E. O., Souza, G. H. M. F., Eberlin, M. N., Marques, L. A., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900104 · Cited by 25
Wada, T., Muraoka, M., Toma, T., Imai, T., Shigemura, T., Agematsu, K., Haraguchi, K., Moriuchi, H., Oh‐ishi, T., Kitoh, T., et al. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9859-9 · Cited by 25
Kawai, T., Kusakabe, H., Seki, A., Kobayashi, S., & Onodera, M. (2011) · Infection · doi:10.1007/s15010-011-0080-1 · Cited by 25
Targeting the host–pathogen interface for treatment of Staphylococcus aureus infection
Park, B., & Liu, G. Y. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0297-1 · Cited by 25
Gene therapy for primary immunodeficiencies
Fox, T. A., & Booth, C. (2020) · British Journal of Haematology · doi:10.1111/bjh.17269 · Cited by 27
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease
Migliavacca, M., Assanelli, A. A., Ferrua, F., Cicalese, M. P., Biffi, A., Frittoli, M. C., Silvani, P., Chidini, G., Calderini, E., Mandelli, A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.01.033 · Cited by 24
Wang, Y., Marciano, B. E., Shen, D., Bishop, R. J., Park, S., Holland, S. M., & Chan, C. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9899-9 · Cited by 24
Self-citationKütükçüler, N., Aykut, A., Karaca, N. E., Durmaz, A., Aksu, G., Genel, F., Parıltay, E., Çoğulu, Ö., & Azarsız, E. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12737 · Cited by 23
Protein kinase C activates NAD kinase in human neutrophils
Rabani, R., Cossette, C., Graham, F. D., & Powell, W. S. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.09.022 · Cited by 23
Solomon, L. A., Podder, S., He, J., Jackson-Chornenki, N. L., Gibson, K., Ziliotto, R. G., Rhee, J., & DeKoter, R. P. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00013-17 · Cited by 22
An, J., Chung, A., & Churchill, D. G. (2023) · Molecules · doi:10.3390/molecules28135234 · Cited by 22
Stein, S., Scholz, S., Schwäble, J., Sadat, M., Modlich, U., Schultze‐Strasser, S., Diaz, M., Chen-Wichmann, L., Müller-Kuller, U., Brendel, C., et al. (2013) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2013.019 · Cited by 23
Marzollo, A., Conti, F., Rossini, L., Rivalta, B., Leonardi, L., Tretti, C., Tosato, F., Chiriaco, M., Ursu, G. M., Natalucci, C. T., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01159-4 · Cited by 22
Successful HLA haploidentical hematopoietic SCT in chronic granulomatous disease
Hoenig, M., Niehues, T., Siepermann, K., Jacobsen, E.-M., Schütz, C., Furlan, I., Dückers, G., Lahr, G., Wiesneth, M., Debatin, K., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.125 · Cited by 22
NADPH Oxidase 2–Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function
Chen, J., Liu, C., Chernatynskaya, A., Newby, B. N., Brusko, T. M., Xu, Y., Barra, J. M., Morgan, N. N., Santarlas, C., Reeves, W. H., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200691 · Cited by 21
Diabetes, Renal and Cardiovascular Disease in p47 phox−/− Chronic Granulomatous Disease
Leiding, J. W., Marciano, B. E., Zerbe, C. S., Ravin, S. S. D., Malech, H. L., & Holland, S. M. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9871-8 · Cited by 23
Self-citationPhellinus tropicalis Abscesses in a Patient with Chronic Granulomatous Disease
Ramesh, M., Resnick, E. S., Hui, Y., Maglione, P. J., Mehta, H., Kattan, J. D., Bouvier, N. M., LaBombardi, V. J., Victor, T. R., Chaturvedi, S., et al. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9967-1 · Cited by 21
Primary Immunodeficiencies: “New” Disease in an Old Country
Lee, P. P. W., & Lau, Y. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.51 · Cited by 21
Gonyar, L. A., Fankhauser, S. C., & Goldberg, J. B. (2014) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12217 · Cited by 20
Interstitial Lung Disease with Multiple Microgranulomas in Chronic Granulomatous Disease
Kawai, T., Watanabe, N., Yokoyama, M., Nakazawa, Y., Goto, F., Uchiyama, T., Higuchi, M., Maekawa, T., Tamura, E., Nagasaka, S., et al. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0089-1 · Cited by 19
Susceptibility to infection in early life: a growing role for human genetics
Borghesi, A., Marzollo, A., Michev, A., & Fellay, J. (2020) · Human Genetics · doi:10.1007/s00439-019-02109-2 · Cited by 19
Late diagnosis of chronic granulomatous disease
Barkai, T., Somech, R., Broides, A., Gavrieli, R., Wolach, B., Marcus, N., Hagin, D., & Stauber, T. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13474 · Cited by 19
Canning, J. S., Laucirica, D. R., Ling, K., Nicol, M. P., Stick, S. M., & Kicic, A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1476041 · Cited by 19
Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy
Paterson, M. J., Caldera, J. R., Nguyen, C., Sharma, P., Castro, A., Kolar, S. L., Tsai, C., Limon, J. J., Becker, C. A., Martins, G. A., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008733 · Cited by 19
Mmonu, N. A., Rastinehad, A. R., Richter, L. A., Barak, S., Zerbe, C. S., Holland, S. M., & Pinto, P. A. (2012) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2011.11.003 · Cited by 19
Self-citationChronic Granulomatous Disease Associated with Atypical Kawasaki Disease
Yamazaki‐Nakashimada, M. A., Ramírez-Vargas, N. G., & Rubens-Figueroa, J. D. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9011-4 · Cited by 19
Babiker, A., Gupta, N., Gibas, C. F. C., Wiederhold, N. P., Sanders, C. J., Mele, J., Fan, H., Iovleva, A., Haidar, G., & Fernandes, C. (2019) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2019.04.002 · Cited by 19
Morphological and molecular identification of cellulolytic fungi associated with local raru species
Elfiati, D., Susilowati, A., Modes, C., & Rachmat, H. H. (2019) · Biodiversitas Journal of Biological Diversity · doi:10.13057/biodiv/d200833 · Cited by 18
The E3 ubiquitin ligase RNF186 and RNF186 risk variants regulate innate receptor-induced outcomes
Ranjan, K., Hedl, M., & Abraham, C. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013500118 · Cited by 18
Jorge, C. D., Borges, N., & Santos, H. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12734 · Cited by 18
Sun, J., Wang, Y., Liu, D., Yu, Y., Wang, J., Ying, W., & Wang, X. (2012) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2012.02772.x · Cited by 18
Germ‐free mice deficient of reactive oxygen species have increased arthritis susceptibility
Wing, K., Klocke, K., Samuelsson, A., & Holmdahl, R. (2015) · European Journal of Immunology · doi:10.1002/eji.201445020 · Cited by 19
Ryan, S. O., Johnson, J. L., & Cobb, B. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203404 · Cited by 18
Sacco, K. A., Smith, M. J., Bahna, S. L., Buchbinder, D. K., Burkhardt, J., Cooper, M. A., Hartog, N., Kobrynski, L. J., Patel, K. P., & Abraham, R. S. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00712-6 · Cited by 19
Álvarez, B., Arcos, J., & Fernández-Guerrero, M. L. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283455c0b · Cited by 17
Gene Therapy for Primary Immunodeficiency
Houghton, B. C., & Booth, C. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000509 · Cited by 19
The role of reactive oxygen intermediates in experimental coccidioidomycois in mice
Margolis, D. A., Viriyakosol, S., Fierer, J., & Kirkland, T. N. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-71 · Cited by 17
Silva‐Santana, G., Sales, F., Aguiar, A. P., & Brandão, M. L. L. (2025) · Processes · doi:10.3390/pr13051270 · Cited by 16
NOX2 Is Critical to Endocardial to Mesenchymal Transition and Heart Development
Moazzen, H., Wu, Y., Engineer, A., Lu, X., Aulakh, S., & Feng, Q. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1679045 · Cited by 17
Peterson, K. L., Reid, W. C., Freeman, A. F., Holland, S. M., Pettigrew, R. I., Gharib, A. M., & Hammoud, D. A. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.01.005 · Cited by 16
Self-citationPsychrobacter Infections in Humans—A Narrative Review of Reported Cases
Ιωάννου, Π., Ziogou, A., Giannakodimos, A., Giannakodimos, I., Tsantes, A. G., & Samonis, G. (2025) · Antibiotics · doi:10.3390/antibiotics14020140 · Cited by 15
Ling, Z., Dong, L., Gao, Z., Yu, X., & Lu, D. (2016) · Pediatric Transplantation · doi:10.1111/petr.12861 · Cited by 15
Yu, L., Li, W., Lv, G., Sun, G., Yang, L., Chen, J., Zhou, L., Ding, Y., Zhang, Z., Tang, X., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01347-w · Cited by 15
Immune chromatin reader SP140 regulates microbiota and risk for inflammatory bowel disease
Fraschilla, I. R., Amatullah, H., Rahman, R., & Jeffrey, K. L. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.08.018 · Cited by 18
Obar, J. J., Hohl, T. M., & Cramer, R. A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.05.015 · Cited by 15
Farinelli, G., Hernández, R. J., Rossi, A., Ranucci, S., Sanvito, F., Migliavacca, M., Brombin, C., Pramov, A., Serio, C. D., Bovolenta, C., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.150 · Cited by 15
Diagnostic evaluation of bronchiectasis
Chan, E. D., Wooten, W. I., Hsieh, E. W. Y., Johnston, K. L., Shaffer, M., Sandhaus, R. A., & van de Veerdonk, F. L. (2019) · Respiratory Medicine X · doi:10.1016/j.yrmex.2019.100006 · Cited by 14
Pokhrel, S., Triplett, K. D., Daly, S. M., Joyner, J. A., Sharma, G., Hathaway, H. J., Prossnitz, E. R., & Hall, P. R. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000545 · Cited by 14
Esenboğa, S., Emiralioğlu, N., Cağdaş, D. N., Erman, B., de Boer, M., Oguz, B. S., Ki̇per, N., & Tezcan, İ. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0376-8 · Cited by 14
Otitis Media in Children with Congenital Immunodeficiencies
Urschel, S. (2010) · Current Allergy and Asthma Reports · doi:10.1007/s11882-010-0143-x · Cited by 14
Wen, T., Xiong, S., Zhao, H., Wang, J., Wang, C., Long, Z., Xiong, L., & Qian, G. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae041 · Cited by 13
Patıroğlu, T., Güngör, H. E., Lazaroski, S., & Ünal, E. (2013) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.60.2013.2.6 · Cited by 13
Cellular crosstalk between TNF-α, NADPH oxidase, PKCβ2, and C2GNT in human leukocytes.
Tarr, J., Ding, N., Kaul, K., Antonell, A., Pérez-Jurado, L., & Chibber, R. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.003 · Cited by 12
Chen, X., Wang, D., Lan, J., Wang, G., Zhu, L., Xu, X., Zhai, X., Xu, H. M., & Li, Z. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4124 · Cited by 13
Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis
Kawai, T., Arai, K., Harayama, S., Nakazawa, Y., Goto, F., Maekawa, T., Tamura, E., Uchiyama, T., & Onodera, M. (2015) · Journal of Clinical Immunology · doi:10.1007/s10875-015-0180-2 · Cited by 13
Generation of a conditional null allele of NADPH oxidase activator 1 (NOXA1)
Flaherty, J. P., Spruce, C. A., Fairfield, H. E., & Bergstrom, D. E. (2010) · genesis · doi:10.1002/dvg.20655 · Cited by 14
Shigemura, T., Nakazawa, Y., Amano, Y., Sudo, A., Watanabe, M., Kobayashi, M., Kobayashi, N., Koike, K., Agematsu, K., & Nishimura, K. (2015) · Infection · doi:10.1007/s15010-015-0724-7 · Cited by 13
How should eosinophilic cystitis be treated in patients with chronic granulomatous disease?
Claps, A., Corte, M. D., Nappo, S. G., Francalanci, P., Palma, P., & Finocchi, A. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2883-7 · Cited by 13
Primary Immunodeficiency in the NICU
O’Connell, A. E. (2019) · NeoReviews · doi:10.1542/neo.20-2-e67 · Cited by 13
Liu, S.-Y., Wang, W.-Z., Yen, C., Tsai, M.-Y., Yang, P.-W., Wang, J., Ho, C.-Y., & Shieh, C.-C. K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.008 · Cited by 13
Teng, J., Li, Y., Zhao, Y., Zhang, Y., Chen, D., Liu, J., Cui, M., & Ji, X. S. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1482901 · Cited by 12
Chronic Granulomatous Disease Masquerading as Behçet Disease
Thomsen, I. P., Dulek, D. E., Creech, C. B., Graham, T. B., & Williams, J. V. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182481ed9 · Cited by 12
Pediatric inflammatory bowel disease: specificity of very early onset
Capriati, T., Cardile, S., Papadatou, B., Romano, C., Knafelz, D., Bracci, F., & Diamanti, A. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1184571 · Cited by 12
The Relationship of X-Linked Primary Immune Deficiencies and Autoimmunity
Pessach, I. M. (2010) · Current Allergy and Asthma Reports · doi:10.1007/s11882-010-0127-x · Cited by 12
Francisella philomiragia Septicemia in a Dog
Cora, M. C., Neel, J. A., Tarigo, J. L., Post, K. W., & Barnes, J. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0545.x · Cited by 11
Vinh, D. C. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.919224 · Cited by 11
McAvoy, A. C., Threatt, P. H., Kapcia, J., & Garg, N. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00529 · Cited by 10
Metadata
- Authors
- Holland, S. M.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Holland, Steven M.
- ORCID
- Holland, Steven M.
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2009-06-09
- Volume
- 38
- Issue
- 1
- Pages
- 3-10
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W2052012325
- Cited by
- 328
- References
- 65
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 10 · 2023: 7 · 2022: 8 · 2021: 20 · 2020: 12 · 2019: 16 · 2018: 15 · 2017: 19 · 2016: 21 · 2015: 19 · 2014: 29 · 2013: 43 · 2012: 27
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- NHLBI Division of Intramural Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- chronic granulomatous disease, neutrophil dysfunction, inflammatory bowel disease, X-linked CGD, autosomal recessive CGD, bone marrow transplantation, gene therapy, inflammatory complications, life expectancy
- MeSH terms
- Animals, Anti-Bacterial Agents, Antifungal Agents, Granulomatous Disease, Chronic, Humans, Interferon-gamma, Genetic Therapy, Bone Marrow Transplantation, NADPH Oxidases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review